Artificial Intelligence is fastest growing segment fueling the growth of Non-Small Cell Lung Cancer Market

-

The global Non-Small Cell Lung Cancer Market is estimated to be valued at US$ 27,252.31 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It develops in the cells lining the alveoli in the lungs. NSCLC comprises approximately 85% of all lung cancers and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Early detection of NSCLC is crucial for improved treatment outcomes.

Market key trends:
Emerging new technologies for NSCLC diagnosis and treatment, such as artificial intelligence, are contributing significantly to the growth of the non-small cell lung cancer market. Artificial intelligence algorithms can analyze complex medical imaging data, like CT scans, and detect lung cancers with high accuracy. They also provide prognosis of cancer stages which helps doctors customize treatment plans. Such technological advancements are enabling early detection of NSCLC, improving treatment outcomes and boosting the demand for non-small cell lung cancer diagnostics and therapeutics.

Segment Analysis
The global non-small cell lung cancer market size is segmented by disease type, treatment type, end user and region. By disease type, the squamous cell carcinoma segment dominated the market in 2022 due to high prevalence. Squamous cell carcinoma accounts for about 25-30% of all lung cancer cases. By treatment type, the chemotherapy segment accounted for the largest share as chemotherapy is the primary treatment approach for NSCLC.

Key Takeaways
The global non-small cell lung cancer market size was valued at US$ 27252.31 Mn in 2023 and is expected to grow at a CAGR of 9.4% during the forecast period. Driven by rising tobacco consumption and increasing air pollution across emerging economies.

Regional analysis: North America dominated the global non-small cell lung cancer market in 2023 and is expected to maintain its dominance over the forecast period. This is attributed to increasing prevalence of lung cancer and growing adoption of advanced technologies in the region.

Key players: Key players operating in the non-small cell lung cancer market include Pfizer Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Boehringer Ingelheim GMBH, Novartis AG, Bristol-Myers Squibb Company, and Merck & Co., Inc. Pfizer Inc. dominates the market with its newer drugs launched for NSCLC treatment.

Comments

Post a Comment

Popular posts from this blog

The global Calcium Citrate Malate Market Growth Accelerated by Expanding Applications

-
Image
Calcium citrate malate is an essential mineral compound that provides calcium and supports bone health. Calcium citrate malate supplements help maintain healthy bones and teeth as we age. They support calcium absorption and distribution throughout the body. The global Calcium Citrate Malate Market is estimated to be valued at US$ 334.08 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The expanding applications of calcium citrate malate are expected to drive the market growth over the forecast period. Calcium citrate malate supplements are increasingly being used to prevent and treat osteoporosis. They are especially recommended for people who cannot digest lactose or avoid dairy products. The compound is also finding wider use in functional foods and beverages with added calcium and minerals. Manufacturers are developing various product formats like...
Read more

Labor Productivity Tracking Market Growth Accelerated by Remote Work and Digitalization Trend

-
Image
Labor productivity tracking solutions help businesses and organizations track employee productivity in real-time. These solutions offer features like time tracking, activity monitoring, goal setting, resource allocation, attendance logging, and analytics. They help enhance productivity by identifying opportunities for improvement, streamlining workflows, and ensuring employees are focused on tasks that add value. The global Labor Productivity Tracking Market is estimated to be valued at US$ 6.81 Billion in 2024 and is expected to exhibit a CAGR of 38% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rapid adoption of remote work and digitalization trend across industries during the pandemic has been a major driver accelerating growth of the labor productivity tracking market. Many organizations have now accepted work from home and hybrid work models. Labor productivity tracking solutions help employers...
Read more

Tamponades is fastest growing segment fueling the growth of the Global Vitreous Tamponades Market

-
Image
The global Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview : Vitreous tamponades are substances used to seal retinal breaks and provide internal tamponade during vitrectomy surgeries. They help stabilize the retina and promote posterior vitreous detachment. The different types of tamponades include gases, silicone oils and perfluoro-n-octane. Market key trends : One of the key trends in the market is the preference for non-silicone tamponades over traditional silicone oils. Silicone oils have been commonly used but are difficult to remove and can cause complications. Newer tamponades such as perfluorocarbon liquids and gases provide effective internal tamponade with better removal properties. They minimize complications and improve surgical outcomes leading to their increased demand. Segment ...
Read more